Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 04:00PM ET
3.23
Dollar change
-0.03
Percentage change
-0.92
%
Index- P/E- EPS (ttm)-1.10 Insider Own31.98% Shs Outstand42.18M Perf Week-5.00%
Market Cap137.11M Forward P/E- EPS next Y-3.25 Insider Trans-0.16% Shs Float28.87M Perf Month0.94%
Income-45.69M PEG- EPS next Q-0.87 Inst Own52.83% Short Float1.82% Perf Quarter-51.06%
Sales97.86M P/S1.40 EPS this Y-3.84% Inst Trans-4.79% Short Ratio2.40 Perf Half Y-32.99%
Book/sh5.46 P/B0.59 EPS next Y-40.38% ROA-15.25% Short Interest0.52M Perf Year-68.64%
Cash/sh5.58 P/C0.58 EPS next 5Y- ROE-18.91% 52W Range2.98 - 13.85 Perf YTD-55.75%
Dividend Est.- P/FCF- EPS past 5Y-41.74% ROI-19.65% 52W High-76.68% Beta0.71
Dividend TTM- Quick Ratio8.33 Sales past 5Y1420.60% Gross Margin96.83% 52W Low8.39% ATR (14)0.26
Dividend Ex-Date- Current Ratio8.33 EPS Y/Y TTM-56.37% Oper. Margin-71.17% RSI (14)40.66 Volatility6.99% 7.52%
Employees179 Debt/Eq0.01 Sales Y/Y TTM-28.62% Profit Margin-46.69% Recom1.43 Target Price15.33
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q135.98% Payout- Rel Volume0.52 Prev Close3.26
Sales Surprise36.47% EPS Surprise1810.83% Sales Q/Q822.93% EarningsMay 07 AMC Avg Volume218.54K Price3.23
SMA20-5.71% SMA50-14.60% SMA200-48.75% Trades Volume112,562 Change-0.92%
Date Action Analyst Rating Change Price Target Change
Jun-09-23Upgrade Stifel Hold → Buy $11 → $16
Feb-03-23Downgrade Morgan Stanley Overweight → Equal-Weight $28 → $15
Jan-06-23Initiated CapitalOne Overweight $28
Apr-12-22Downgrade Stifel Buy → Hold $11
Mar-17-22Resumed Goldman Buy $43
Sep-23-21Initiated Stifel Buy $48
Sep-13-21Initiated H.C. Wainwright Buy $54
Jun-28-21Initiated Guggenheim Buy $46
Mar-01-21Initiated Berenberg Buy $51
Oct-28-20Initiated Northland Capital Outperform $38
Today 07:05AM
May-08-24 07:39AM
07:31AM
May-07-24 10:55PM
04:05PM
07:05AM Loading…
Apr-30-24 07:05AM
07:05AM
Apr-26-24 04:05PM
Feb-29-24 07:05AM
Feb-28-24 07:36AM
07:05AM
Feb-20-24 10:00AM
Feb-15-24 07:05AM
Feb-13-24 04:45AM
Feb-12-24 04:05PM
07:00AM Loading…
Jan-25-24 07:00AM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-29-23 04:05PM
Nov-20-23 08:19AM
Nov-15-23 07:00AM
Nov-09-23 11:38AM
08:16AM
07:00AM
Nov-07-23 07:00AM
Nov-06-23 11:35AM
07:00AM
Oct-13-23 09:40AM
Oct-11-23 09:35AM
Oct-09-23 09:35AM
07:00AM Loading…
Oct-03-23 07:00AM
Sep-20-23 04:26AM
Sep-19-23 07:00AM
Sep-06-23 07:00AM
Aug-31-23 10:12PM
Aug-16-23 02:54PM
Aug-09-23 05:40PM
04:05PM
Aug-05-23 03:30PM
Jul-16-23 10:36AM
Jun-08-23 09:49AM
07:00AM
Jun-07-23 04:05PM
Jun-06-23 07:00AM
Jun-05-23 06:36AM
Jun-02-23 07:00AM
May-22-23 07:00AM
May-14-23 08:04AM
May-12-23 06:19AM
May-11-23 06:13AM
May-09-23 06:55PM
04:05PM
May-03-23 09:55AM
Apr-28-23 04:05PM
Apr-18-23 02:32PM
10:15AM
Mar-29-23 07:25AM
Mar-14-23 04:58PM
Mar-02-23 05:39AM
Feb-28-23 08:15PM
04:05PM
Feb-06-23 05:18AM
Feb-02-23 07:00AM
Jan-24-23 04:33AM
Jan-20-23 09:55AM
Jan-19-23 07:00AM
Dec-27-22 05:34AM
Dec-19-22 07:00AM
Dec-02-22 10:54AM
09:35AM
Dec-01-22 09:55AM
Nov-16-22 05:35AM
Nov-14-22 09:55AM
Nov-09-22 05:35PM
04:05PM
Nov-07-22 07:00AM
Oct-13-22 11:08AM
Oct-12-22 09:10AM
Sep-07-22 07:17AM
07:00AM
Aug-11-22 06:55AM
Aug-04-22 06:35PM
04:05PM
Jun-30-22 01:08PM
Jun-07-22 07:00AM
Jun-02-22 03:26PM
12:30PM
11:01AM
08:00AM
Jun-01-22 06:03PM
04:05PM
May-09-22 07:00AM
May-05-22 08:35PM
04:05PM
09:04AM
May-04-22 05:25PM
Apr-20-22 11:00AM
Apr-13-22 08:24AM
Apr-12-22 09:32AM
Apr-11-22 04:05PM
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Segal Lloyd MitchellPRESIDENT AND CEOApr 01 '24Sale4.632,49111,533107,558Apr 01 09:31 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERApr 01 '24Sale4.617893,63744,775Apr 01 09:30 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERApr 01 '24Sale4.664101,91171,908Apr 01 09:28 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERApr 01 '24Sale4.663001,398231,409Apr 01 09:27 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 28 '24Sale4.622,65012,243110,049Apr 01 09:31 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 28 '24Sale4.628253,81245,564Apr 01 09:30 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 28 '24Sale4.645002,320231,709Apr 01 09:27 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 28 '24Sale4.644502,08872,318Apr 01 09:28 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 27 '24Sale4.632,65012,27083,866Mar 27 06:54 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 27 '24Sale4.628253,81242,212Mar 27 06:59 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 27 '24Sale4.625002,310232,209Mar 27 06:56 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 27 '24Sale4.624502,07972,768Mar 27 06:57 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 26 '24Sale4.642,65012,29686,516Mar 27 06:54 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 26 '24Sale4.608253,79543,037Mar 27 06:59 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 26 '24Sale4.605002,300232,709Mar 27 06:56 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 26 '24Sale4.614502,07473,218Mar 27 06:57 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 25 '24Sale4.792,65012,69489,166Mar 27 06:54 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 25 '24Sale4.798253,95243,862Mar 27 06:59 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 25 '24Sale4.785002,390233,209Mar 27 06:56 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 25 '24Sale4.784502,15173,668Mar 27 06:57 PM
Koehler MariaEVP, Chief Medical OfficerDec 11 '23Option Exercise2.2643,74698,755219,709Dec 12 04:19 PM
BVF PARTNERS L P/IL10% OwnerNov 16 '23Buy5.38295,7451,592,2025,309,432Nov 17 04:54 PM
BVF PARTNERS L P/IL10% OwnerNov 15 '23Buy5.00931,5564,657,6875,155,739Nov 17 04:54 PM
BVF PARTNERS L P/IL10% OwnerNov 02 '23Buy3.60783,7092,821,3524,662,402Nov 03 05:37 PM
Zinda MichaelEVP, Chief Scientific OfficerJun 07 '23Sale12.036,40477,04062,987Jun 09 04:25 PM
Zinda MichaelEVP, Chief Scientific OfficerJun 06 '23Sale12.041,20014,44869,391Jun 07 04:55 PM